116 related articles for article (PubMed ID: 25489255)
1. Health system costs for stage-specific breast cancer: a population-based approach.
Mittmann N; Porter JM; Rangrej J; Seung SJ; Liu N; Saskin R; Cheung MC; Leighl NB; Hoch JS; Trudeau M; Evans WK; Dainty KN; DeAngelis C; Earle CC
Curr Oncol; 2014 Dec; 21(6):281-93. PubMed ID: 25489255
[TBL] [Abstract][Full Text] [Related]
2. Cost-of-illness study for non-small-cell lung cancer using real-world data.
Seung SJ; Hurry M; Hassan S; Walton RN; Evans WK
Curr Oncol; 2019 Apr; 26(2):102-107. PubMed ID: 31043811
[TBL] [Abstract][Full Text] [Related]
3. Costs of cervical cancer treatment: population-based estimates from Ontario.
Pendrith C; Thind A; Zaric GS; Sarma S
Curr Oncol; 2016 Apr; 23(2):e109-15. PubMed ID: 27122978
[TBL] [Abstract][Full Text] [Related]
4. Population-based home care services in breast cancer: utilization and costs.
Mittmann N; Isogai PK; Saskin R; Liu N; Porter JM; Cheung MC; Leighl NB; Hoch JS; Trudeau ME; Evans WK; Dainty KN; Earle CC
Curr Oncol; 2012 Dec; 19(6):e383-91. PubMed ID: 23300362
[TBL] [Abstract][Full Text] [Related]
5. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
[TBL] [Abstract][Full Text] [Related]
6. The impact of including future medical care costs when estimating the costs attributable to a disease: a colorectal cancer case study.
Etzioni R; Ramsey SD; Berry K; Brown M
Health Econ; 2001 Apr; 10(3):245-56. PubMed ID: 11288190
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and therapeutic approaches for nonmetastatic breast cancer in Canada, and their associated costs.
Will BP; Le Petit C; Berthelot JM; Tomiak EM; Verma S; Evans WK
Br J Cancer; 1999 Mar; 79(9-10):1428-36. PubMed ID: 10188886
[TBL] [Abstract][Full Text] [Related]
8. Utilization and costs of home care for patients with colorectal cancer: a population-based study.
Mittmann N; Liu N; Porter J; Seung SJ; ; Isogai PK; Saskin R; Cheung MC; Leighl NB; Hoch JS; Trudeau M; Evans WK; Dainty KN; Earle CC
CMAJ Open; 2014 Jan; 2(1):E11-7. PubMed ID: 25077120
[TBL] [Abstract][Full Text] [Related]
9. Real-World Treatment Patterns, Survival, and Costs for Ovarian Cancer in Canada: A Retrospective Cohort Study Using Provincial Administrative Data.
Hurry M; Hassan S; Seung SJ; Walton RN; Elnoursi A; McGee JD
J Health Econ Outcomes Res; 2021; 8(2):114-121. PubMed ID: 34993257
[No Abstract] [Full Text] [Related]
10. Healthcare costs associated with prostate cancer: estimates from a population-based study.
Krahn MD; Zagorski B; Laporte A; Alibhai SM; Bremner KE; Tomlinson G; Warde P; Naglie G
BJU Int; 2010 Feb; 105(3):338-46. PubMed ID: 19594734
[TBL] [Abstract][Full Text] [Related]
11. Trends in health care utilization and costs attributable to hepatocellular carcinoma, 2002-2009: a population-based cohort study.
Thein HH; Qiao Y; Young SK; Zarin W; Yoshida EM; de Oliveira C; Earle CC
Curr Oncol; 2016 Jun; 23(3):e196-220. PubMed ID: 27330357
[TBL] [Abstract][Full Text] [Related]
12. End-of-life home care utilization and costs in patients with advanced colorectal cancer.
Mittmann N; Liu N; Porter JM; Isogai PK; Saskin R; Cheung MC; Leighl NB; Hoch JS; Trudeau ME; Evans WK; Dainty KN; Earle CC
J Community Support Oncol; 2014 Mar; 12(3):92-8. PubMed ID: 24971414
[TBL] [Abstract][Full Text] [Related]
13. Resource utilization and costs of managing patients with advanced melanoma: a Canadian population-based study.
Gwadry-Sridhar F; Nikan S; Hamou A; Seung SJ; Petrella T; Joshua AM; Ernst S; Mittmann N
Curr Oncol; 2017 Jun; 24(3):168-175. PubMed ID: 28680276
[TBL] [Abstract][Full Text] [Related]
14. A multicenter, retrospective pilot study of resource use and costs associated with severity of disease in glaucoma.
Lee PP; Walt JG; Doyle JJ; Kotak SV; Evans SJ; Budenz DL; Chen PP; Coleman AL; Feldman RM; Jampel HD; Katz LJ; Mills RP; Myers JS; Noecker RJ; Piltz-Seymour JR; Ritch RR; Schacknow PN; Serle JB; Trick GL
Arch Ophthalmol; 2006 Jan; 124(1):12-9. PubMed ID: 16401779
[TBL] [Abstract][Full Text] [Related]
15. Health care resource use associated with integrated psychological treatment.
Vasiliadis HM; Briand C; Lesage A; Reinharz D; Stip E; Nicole L; Lalonde P
J Ment Health Policy Econ; 2006 Dec; 9(4):201-7. PubMed ID: 17200597
[TBL] [Abstract][Full Text] [Related]
16. A population-based study of the resource utilization and costs of managing resectable non-small cell lung cancer.
Mahar AL; Coburn NG; Johnson AP
Lung Cancer; 2014 Nov; 86(2):281-7. PubMed ID: 25267166
[TBL] [Abstract][Full Text] [Related]
17. Utilization and costs for children who have special health care needs and are enrolled in a hospital-based comprehensive primary care clinic.
Berman S; Rannie M; Moore L; Elias E; Dryer LJ; Jones MD
Pediatrics; 2005 Jun; 115(6):e637-42. PubMed ID: 15930189
[TBL] [Abstract][Full Text] [Related]
18. Direct costs of adult traumatic spinal cord injury in Ontario.
Munce SE; Wodchis WP; Guilcher SJ; Couris CM; Verrier M; Fung K; Craven BC; Jaglal SB
Spinal Cord; 2013 Jan; 51(1):64-9. PubMed ID: 22801189
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis.
Pelletier EM; Shim B; Goodman S; Amonkar MM
Breast Cancer Res Treat; 2008 Mar; 108(2):297-305. PubMed ID: 17577662
[TBL] [Abstract][Full Text] [Related]
20. Estimating the cost of lung cancer diagnosis and treatment in Canada: the POHEM model.
Evans WK; Will BP; Berthelot JM; Wolfson MC
Can J Oncol; 1995 Dec; 5(4):408-19. PubMed ID: 8770457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
